CRMD Q4 2022 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,702-47.3% YoY

Gross Profit

$29,29698.6% margin

Operating Income

-$8M-28244.7% margin

Net Income

-$8M-27637.7% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+335.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$874,051

Balance Sheet

Total Assets

$62M

Total Liabilities

$7M

Stockholders' Equity

$55M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,702	$56,397	-47.3%
Gross Profit	$29,296	$8,390	+249.2%
Operating Income	-$8M	-$8M	-7.8%
Net Income	-$8M	-$8M	-5.4%